George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
Naewise- I agree. Nothing concrete just speculation. This company has in my eyes failed its shareholders in the last few years not updating us as often as we would like. If there is a reason they have though, it will all come out hopefully soon. I have low expectation, high hopes.
U.S. Application No. 17/133,448
Title: METHOD OF ELIMINATING HEMATOPOIETIC STEM CELLS/HEMATOPOIETIC
PROGENITORS (HSC/HP) IN A PATIENT USING BI-SPECIFIC ANTIBODIES
Applicant: HEMOGENYX LLC
Inventor: Vladislav Sandler
Issued as U.S. Patent No. 11,945,866 on April 2, 2024.
“Research continues on CBR and the Company intends to increase its focus on this once HEMO-CAR-T has entered clinical trials.“
CAR-T is technically clinical right, although not started trials. What’s people’s thoughts? Selling off this part of the company to fund others.
Either way what a week for RNSs, trust in the science and the SP will follow.
JHFH, if they receive it, is Hemo/Vlad allowed to not RNS it. And wait until it’s better timing. Isn't that withholding sensitive information?
I thought once he receives it, it will be then and there or 7AM next working day.
I know £80k is a big buy, but in the grand scheme of things is it? I don’t like putting out prediction but in 5 years I would love to know what this will be valued at.
Generally I find AIM is a loosing game. But occasionally you do get some gems. I’m hoping this is one of them.
Someone sold. In all seriousness no big sales went through when looking at the trades. Less than £70,000 was bought/sold. Small volume today really. A day closer to the RNS we are waiting for. Good or bad, this 6% won’t matter the day of the RNS.
Generally with investments it’s the case. But at this market cap I just don’t think I can. I’m not touching these shares. I’ve had bad luck with synairgen, still hold them. It was a risk I saw worth risking it for. I’m not selling either way. The potential is here with hemo, trust in the science and cross your fingers.
i think there is a lot of ****ging off the bod, and sometimes i think rightly too. however, pharma isn’t simple. the goal is commercialisation. to achieve this we need successful trials. to get successful trials we need data and plans. there is little room for error. personally i hold faith, my biggest concern is will the company go bankrupt before we reach the end goal of commercialisation? it seems to me they are quietly making plans right now and have gathered a lot of data, the need for the drug hasn’t gone away.